Orthopediatrics (NASDAQ: KIDS) and Stryker (NYSE:SYK) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, risk, profitability, institutional ownership, earnings and dividends.
This table compares Orthopediatrics and Stryker’s net margins, return on equity and return on assets.
This is a summary of recent recommendations for Orthopediatrics and Stryker, as reported by MarketBeat.
Orthopediatrics currently has a consensus price target of $23.67, indicating a potential upside of 35.24%. Stryker has a consensus price target of $163.74, indicating a potential downside of 1.61%. Given Orthopediatrics’ stronger consensus rating and higher probable upside, equities analysts clearly believe Orthopediatrics is more favorable than Stryker.
Institutional & Insider Ownership
32.5% of Orthopediatrics shares are held by institutional investors. Comparatively, 75.0% of Stryker shares are held by institutional investors. 7.4% of Stryker shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares Orthopediatrics and Stryker’s gross revenue, earnings per share (EPS) and valuation.
Stryker has higher revenue and earnings than Orthopediatrics.
Stryker pays an annual dividend of $1.88 per share and has a dividend yield of 1.1%. Orthopediatrics does not pay a dividend. Stryker pays out 38.4% of its earnings in the form of a dividend. Stryker has raised its dividend for 7 consecutive years.
Stryker beats Orthopediatrics on 10 of the 13 factors compared between the two stocks.
Orthopediatrics Company Profile
OrthoPediatrics Corp. is a medical device company. The Company designs, develops and commercializes orthopedic implants and instruments to meet the specialized needs of pediatric surgeons and their patients. It operates through the OrthoPediatrics segment, which designs, develops and markets implants and devices for children with orthopedic problems. Its products include RESPONSE Spinal Deformity System, PediNail Intramedullary Nail System, PediLoc Plating Systems, ACL Reconstruction System, Locking Cannulated Blade (LCB) plate system, Locking Proximal Femur (LPF) plate system, PediFlex Flexible Nailing System, PediFrag, PediLoc Extension Osteotomy Plate (PLEO), PediLoc Femur Locking Plate System, PediLoc Tibia Locking Plate System, PediPlates system and Spica Table. It markets over 20 surgical systems that serve approximately three categories within pediatric orthopedic market, including trauma and deformity, complex spine and anterior cruciate ligament reconstruct
Stryker Company Profile
Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products. The MedSurg segment includes surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling, emergency medical equipment, intensive care disposable products; reprocessed and remanufactured medical devices, and other related products. The Neurotechnology and Spine segment includes neurovascular products, spinal implant systems and other related products. The Company’s products include implants, which are used in joint replacement and trauma surgeries, and other products that are used in a range of medical specialties.